(VIANEWS) - Mosaic Company (MOS), Eagle Point Credit Company (ECC), Regeneron Pharmaceuticals (REGN) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Mosaic Company (MOS)
69.7% sales growth and 18.69% return on equity
The Mosaic Company, through its subsidiaries, produces and markets concentrated phosphate and potash crop nutrients in North America and internationally.
Mosaic Company's sales growth this year is expected to be 43.4% and 21.1% for next year.
Year-on-year quarterly revenue growth grew by 43.5%, now sitting on 10.97B for the twelve trailing months.
Volume
Today's last reported volume for Mosaic Company is 6820570 which is 35.66% above its average volume of 5027360.
Mosaic Company's sales growth for the next quarter is 69.7%. The company's growth estimates for the present quarter and the next is 249.1% and 259.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.69%.
Volatility
Mosaic Company's last day, last week, and last month's current intraday variation average was 2.07%, 3.16%, and 2.23%, respectively.
Mosaic Company's highest amplitude of average volatility was 4.34% (day), 5.15% (last week), and 4.67% (last month), respectively.
Mosaic Company's Stock Yearly Top and Bottom Value
Mosaic Company's stock is valued at $43.83 at 19:22 EST, under its 52-week high of $44.49 and way above its 52-week low of $26.77.
Mosaic Company's Moving Average
Mosaic Company's value is way higher than its 50-day moving average of $38.77 and way above its 200-day moving average of $35.69.2. Eagle Point Credit Company (ECC)
55.2% sales growth and 29.67% return on equity
Eagle Point Credit Company Inc. is a closed ended fund launched and managed by Eagle Point Credit Management LLC.
Eagle Point Credit Company's sales growth this year is anticipated to be 36.7% and 27.4% for next year.
Year-on-year quarterly revenue growth grew by 87.3%, now sitting on 88.51M for the twelve trailing months.
Volume
Today's last reported volume for Eagle Point Credit Company is 451187 which is 34.58% above its average volume of 335254.
Eagle Point Credit Company's sales growth for the next quarter is 55.2%. The company's growth estimates for the current quarter and the next is 54.2% and 56%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 29.67%.
Volatility
Eagle Point Credit Company's last day, last week, and last month's current intraday variation average was 1.29%, 0.68%, and 0.61%, respectively.
Eagle Point Credit Company's highest amplitude of average volatility was 1.21% (day), 1.91% (last week), and 1.84% (last month), respectively.
Eagle Point Credit Company's Stock Yearly Top and Bottom Value
Eagle Point Credit Company's stock is valued at $14.14 at 19:22 EST, under its 52-week high of $15.54 and way above its 52-week low of $10.57.
Eagle Point Credit Company's Moving Average
Eagle Point Credit Company's worth is above its 50-day moving average of $14.08 and higher than its 200-day moving average of $13.93.3. Regeneron Pharmaceuticals (REGN)
18.3% sales growth and 51.09% return on equity
Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide.
Regeneron Pharmaceuticals's sales growth this year is expected to be 56.3% and a negative 10.8% for next year.
Year-on-year quarterly revenue growth grew by 50.5%, now sitting on 13.36B for the twelve trailing months.
Volume
Today's last reported volume for Regeneron Pharmaceuticals is 856520 which is 10% above its average volume of 778631.
Regeneron Pharmaceuticals's sales growth for the next quarter is 18.3%. The company's growth estimates for the ongoing quarter and the next is 7.7% and 8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 51.09%.
Volatility
Regeneron Pharmaceuticals's last day, last week, and last month's current intraday variation average was 1.01%, 1.14%, and 1.24%, respectively.
Regeneron Pharmaceuticals's highest amplitude of average volatility was 3.45% (day), 2.51% (last week), and 2.70% (last month), respectively.
Regeneron Pharmaceuticals's Stock Yearly Top and Bottom Value
Regeneron Pharmaceuticals's stock is valued at $608.98 at 19:22 EST, way below its 52-week high of $686.62 and way above its 52-week low of $441.00.
Regeneron Pharmaceuticals's Moving Average
Regeneron Pharmaceuticals's worth is under its 50-day moving average of $610.79 and above its 200-day moving average of $567.66.4. Ulta Beauty (ULTA)
15.7% sales growth and 39.86% return on equity
Ulta Beauty, Inc. operates as a beauty retailer in the United States.
Ulta Beauty's sales growth this year is anticipated to be 35.2% and 7.6% for next year.
Year-on-year quarterly revenue growth grew by 60.2%, now sitting on 7.66B for the twelve trailing months.
Volume
Today's last reported volume for Ulta Beauty is 687539 which is 9.75% below its average volume of 761883.
Ulta Beauty's sales growth is a negative 0% for the present quarter and 15.7% for the next. The company's growth estimates for the present quarter and the next is 40.2% and 16.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 39.86%.
Volatility
Ulta Beauty's last day, last week, and last month's current intraday variation average was 3.68%, 2.30%, and 1.70%, respectively.
Ulta Beauty's highest amplitude of average volatility was 5.50% (day), 3.91% (last week), and 3.15% (last month), respectively.
Ulta Beauty's Stock Yearly Top and Bottom Value
Ulta Beauty's stock is valued at $355.07 at 19:22 EST, way below its 52-week high of $417.85 and way above its 52-week low of $258.00.
Ulta Beauty's Moving Average
Ulta Beauty's value is below its 50-day moving average of $387.53 and higher than its 200-day moving average of $352.83.5. Columbus McKinnon Corporation (CMCO)
10.1% sales growth and 4.41% return on equity
Columbus McKinnon Corporation designs, manufactures, and markets intelligent motion solutions to ergonomically move, lift, position, and secure materials worldwide.
Columbus McKinnon Corporation's sales growth this year is expected to be 36.8% and 10% for next year.
Year-on-year quarterly revenue growth grew by 29.7%, now sitting on 839.42M for the twelve trailing months.
Volume
Today's last reported volume for Columbus McKinnon Corporation is 107536 which is 7.14% above its average volume of 100366.
Columbus McKinnon Corporation's sales growth for the next quarter is 10.1%. The company's growth estimates for the present quarter and the next is 56% and 17.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.41%.
Volatility
Columbus McKinnon Corporation's last day, last week, and last month's current intraday variation average was 1.10%, 1.49%, and 1.38%, respectively.
Columbus McKinnon Corporation's highest amplitude of average volatility was 2.37% (day), 3.74% (last week), and 4.18% (last month), respectively.
Columbus McKinnon Corporation's Stock Yearly Top and Bottom Value
Columbus McKinnon Corporation's stock is valued at $44.44 at 19:22 EST, way under its 52-week high of $57.06 and higher than its 52-week low of $41.01.
Columbus McKinnon Corporation's Moving Average
Columbus McKinnon Corporation's value is below its 50-day moving average of $45.89 and below its 200-day moving average of $47.55.6. Canadian Pacific Railway (CP)
9.8% sales growth and 39.54% return on equity
Canadian Pacific Railway Limited, together with its subsidiaries, owns and operates a transcontinental freight railway in Canada and the United States.
Canadian Pacific Railway's sales growth this year is expected to be 7.7% and 7.3% for next year.
Year-on-year quarterly revenue growth grew by 14.6%, now sitting on 7.89B for the twelve trailing months.
Volume
Today's last reported volume for Canadian Pacific Railway is 3293260 which is 38.31% below its average volume of 5339270.
Canadian Pacific Railway's sales growth is a negative 0% for the present quarter and 9.8% for the next. The company's growth estimates for the current quarter and the next is 27.7% and 11.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 39.54%.
Volatility
Canadian Pacific Railway's last day, last week, and last month's current intraday variation average was 2.49%, 1.80%, and 1.31%, respectively.
Canadian Pacific Railway's highest amplitude of average volatility was 3.88% (day), 2.31% (last week), and 2.24% (last month), respectively.
Canadian Pacific Railway's Stock Yearly Top and Bottom Value
Canadian Pacific Railway's stock is valued at $68.94 at 19:22 EST, way below its 52-week high of $83.07 and higher than its 52-week low of $64.19.
Canadian Pacific Railway's Moving Average
Canadian Pacific Railway's worth is under its 50-day moving average of $71.92 and below its 200-day moving average of $74.16.7. Corning Incorporated (GLW)
9.2% sales growth and 13.26% return on equity
Corning Incorporated engages in display technologies, optical communications, environmental technologies, specialty materials, and life sciences businesses worldwide.
Corning Incorporated's sales growth this year is expected to be 22.4% and 5% for next year.
Year-on-year quarterly revenue growth grew by 20.5%, now sitting on 13.76B for the twelve trailing months.
Volume
Today's last reported volume for Corning Incorporated is 4398640 which is 6.7% below its average volume of 4714600.
Corning Incorporated's sales growth for the next quarter is 9.2%. The company's growth estimates for the ongoing quarter and the next is 34.9% and 11.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.26%.
Volatility
Corning Incorporated's last day, last week, and last month's current intraday variation average was 1.41%, 1.39%, and 1.25%, respectively.
Corning Incorporated's highest amplitude of average volatility was 2.80% (day), 2.15% (last week), and 2.12% (last month), respectively.
Corning Incorporated's Stock Yearly Top and Bottom Value
Corning Incorporated's stock is valued at $40.23 at 19:22 EST, way under its 52-week high of $46.82 and way above its 52-week low of $34.81.
Corning Incorporated's Moving Average
Corning Incorporated's worth is above its 50-day moving average of $37.64 and under its 200-day moving average of $40.64.8. Ameren (AEE)
5.9% sales growth and 10.4% return on equity
Ameren's sales growth this year is anticipated to be 6.1% and 4.4% for next year.
Year-on-year quarterly revenue growth grew by 5.5%, now sitting on 5.74B for the twelve trailing months.
Volume
Today's last reported volume for Ameren is 721506 which is 44.02% below its average volume of 1288930.
Ameren's sales growth for the next quarter is 5.9%. The company's growth estimates for the current quarter and the next is 8.8% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.4%.
Volatility
Ameren's last day, last week, and last month's current intraday variation average was 1.38%, 0.47%, and 0.57%, respectively.
Ameren's highest amplitude of average volatility was 1.86% (day), 2.08% (last week), and 1.83% (last month), respectively.
Ameren's Stock Yearly Top and Bottom Value
Ameren's stock is valued at $83.76 at 19:22 EST, under its 52-week high of $90.77 and way above its 52-week low of $69.79.